Skip to content
lifestyle.latabloid.com/
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
TScan Therapeutics, Inc.
TScan Therapeutics Announces First Patient Dosed in Phase 3 ALLOHA-2™, a Pivotal Trial Evaluating TSC-101 in Patients with Heme Malignancies
July 29, 2026
TScan Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 21, 2026
TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 29th Annual Meeting
May 20, 2026
TScan Therapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference
April 8, 2026
TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
March 4, 2026
TScan Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
February 25, 2026